Literature DB >> 16832842

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.

Diane L Kamen1, Fredrick M Wigley, Alan N Brown.   

Abstract

Renal disease remains a major source of morbidity and mortality in patients with scleroderma (systemic sclerosis, SSc). We describe the clinical course of 3 patients with diffuse cutaneous SSc presenting with renal disease subsequently found to have antibodies to myeloperoxidase (anti-MPO) and crescentic glomerulonephritis. The presence of antineutrophil cytoplasmic antibodies (ANCA) and anti-MPO defines a subset of patients with SSc who are susceptible to crescentic glomerulonephritis. These patients may present in a manner identical to scleroderma renal crisis, yet treatment requirements differ significantly. We suggest that the presence of ANCA be routinely evaluated when faced with renal failure in the setting of SSc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16832842

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.

Authors:  P T Chan; C C Mok
Journal:  Clin Rheumatol       Date:  2012-05-30       Impact factor: 2.980

2.  A 66-Year-Old Woman With Hemoptysis.

Authors:  Falin B Patel; Kara S Couch; Sean McNish; Jonathan D Miller; Robert Siegel; Samantha Easley; Victoria K Shanmugam
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-03       Impact factor: 4.794

3.  Renal disease in systemic sclerosis with normal serum creatinine.

Authors:  Reem H A Mohamed; Hania S Zayed; Amr Amin
Journal:  Clin Rheumatol       Date:  2010-02-23       Impact factor: 2.980

Review 4.  Is there evidence for vasculitis in systemic sclerosis?

Authors:  Lesley Ann Saketkoo; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 5.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

6.  Vasculitis in systemic sclerosis.

Authors:  Lily Kao; Cornelia Weyand
Journal:  Int J Rheumatol       Date:  2010-09-30

Review 7.  A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.

Authors:  Hadim Akoglu; Gokhan Kadir Atilgan; Ramazan Ozturk; Ezgi Coskun Yenigun; Ipek Isik Gonul; Ali Riza Odabas
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

Review 8.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

9.  Scleroderma renal crisis: a pathology perspective.

Authors:  Ibrahim Batal; Robyn T Domsic; Thomas A Medsger; Sheldon Bastacky
Journal:  Int J Rheumatol       Date:  2010-07-28

10.  Scleroderma with crescentic glomerulonephritis: a case report.

Authors:  Arunachalam Ramaswami; Thiraviam Kandaswamy; Tholappan Rajendran; Kizhake Pisharam Jeyakrishnan; Hla Aung; Mohammaed Iqbal; Chakko K Jacob; Haji Shaukat Zinna; Gazala Kafeel
Journal:  J Med Case Rep       Date:  2008-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.